Last reviewed · How we verify

NCT05992233

"Effectiveness of Dual-Wavelength Laser Therapy in Third Molar Extraction Pain, Swelling, and Trismus"

Completed NA Last updated 26 September 2024
What this trial tests

NA trial testing Dual wavelength low level laser in Molar, Third in 40 participants. Completed in 16 December 2022.

Timeline
18 October 2021
Primary endpoint
16 October 2022
16 December 2022

Quick facts

Lead sponsorTokat Gaziosmanpasa University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment40
Start date18 October 2021
Primary completion16 October 2022
Estimated completion16 December 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Tokat Gaziosmanpasa University

Who can join

Adults 18 to 40, any sex, with Molar, Third or Low-level Laser Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: To investigate the effects of single session dual wavelength low dose laser therapy to be applied after third molar tooth extraction on postoperative pain, edema and physical activities. Materials and Methods: Thirty-six patients who applied for the extraction of a Class III and position B lower impacted wisdom tooth were included in the study. The patients were divided into 2 groups as laser and control group. Envelope selection method was used for randomization of patients. After the surgery, a single session of double wavelength low-dose laser therapy was applied to the patients. On the 2nd and 7th postoperative days, pain was measured with the VAS scale, edema was measured by face measurements of 3 different points, and quality of life was measured with the modified Posse scale.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Molar, Third

Currently open trials in the same condition.

Other Tokat Gaziosmanpasa University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05992233.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing